29043-48-9 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Jia, Qiang; Cai, Tingwei; Huang, Mingchuan; Li, Huiying; Xian, Ming; Poulos, Thomas L.; Wang, Peng G.
[Journal of Medicinal Chemistry, 2003, vol. 46, # 12, p. 2271 - 2274]
[2]Belzecki,C. et al.
[Bulletin de l'Academie Polonaise des Sciences, Serie des Sciences Chimiques, 1970, vol. 18, p. 375 - 378]
[3]Current Patent Assignee: C.H. Boehringer Sohn AG & Co. KG - WO2009/70485, 2009, A1
Location in patent: Page/Page column 108
[4]Current Patent Assignee: TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. - US2012/220767, 2012, A1
Location in patent: Page/Page column 10
[5]Oka, Yusuke; Yabuuchi, Tetsuya; Oi, Takahiro; Kuroda, Shoichi; Fujii, Yasuyuki; Ohtake, Hidenori; Inoue, Tomoyuki; Wakahara, Shunichi; Kimura, Kayo; Fujita, Kiyoko; Endo, Mayumi; Taguchi, Kyoko; Sekiguchi, Yoshinori
[Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 24, p. 7578 - 7583]
Reference: [1]Current Patent Assignee: IMMUNE PHARMACEUTICALS INC - US2004/127521, 2004, A1
[2]Ried, Walter; Eichhorn, Thomas A.
[Chemische Berichte, 1988, vol. 121, p. 2049 - 2052]
Reference: [1]Bioorganic and Medicinal Chemistry,2013,vol. 21,p. 7578 - 7583
[2]Patent: US2012/220767,2012,A1 .Location in patent: Page/Page column 10
* For details of the synthesis route, please refer to the original source to ensure accuracy.